We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTO
8751
DELISTED
Altamira Therapeutics Ltd
CYTO
$11K ﹤0.01%
3
-4
-57% -$20.4K
IFMK
8752
DELISTED
iFresh Inc. Common Stock
IFMK
$11K ﹤0.01%
+13,198
New +$19.1K
GNMX
8753
DELISTED
Aevi Genomic Medicine Inc
GNMX
$11K ﹤0.01%
15,774
-1,022
-6% -$1.14K
AMR
8754
PUT
DELISTED
Alta Mesa Resources Inc
AMR
$11K ﹤0.01%
+10,900
New +$27.6K
EPE
8755
DELISTED
EP Energy Corporation
EPE
$11K ﹤0.01%
14,619
+965
+7% +$1.44K
GNCA
8756
DELISTED
Genocea Biosciences, Inc.
GNCA
$11K ﹤0.01%
+4,989
New +$24.8K
CTIC
8757
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$11K ﹤0.01%
15,100
-9,800
-39% -$16.1K
GSAT icon
8758
CALL
Globalstar
GSAT
$10.6B
$10K ﹤0.01%
1,080
-307
-22% -$1.83K
AGIG
8759
Abundia Global Impact Group
AGIG
$40.2M
$10K ﹤0.01%
+408
New +$11.3K
IZEA icon
8760
IZEA Worldwide
IZEA
$55.2M
$10K ﹤0.01%
+2,606
New +$15.1K
PDSB icon
8761
CALL
PDS Biotechnology
PDSB
$13.4M
$10K ﹤0.01%
+1,630
New +$21.6K
PRSO icon
8762
Peraso
PRSO
$10.1M
$10K ﹤0.01%
77
+46
+148% +$8.57K
RGLS
8763
DELISTED
Regulus Therapeutics
RGLS
$10K ﹤0.01%
+1,067
New +$17.7K
VERO
8764
DELISTED
Venus Concept
VERO
$10K ﹤0.01%
+10
New +$38.4K
YTEN
8765
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$10K ﹤0.01%
13
-17
-57% -$20.8K
MLNT
8766
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$10K ﹤0.01%
2,520
-1,580
-39% -$20.2K
HLTH
8767
CALL
DELISTED
Nobilis Health Corp.
HLTH
$10K ﹤0.01%
+22,700
New +$13.4K
ARCW
8768
DELISTED
ARC Group Worldwide, Inc
ARCW
$10K ﹤0.01%
+10,424
New +$16K
VRML
8769
DELISTED
Vermillion, Inc.
VRML
$10K ﹤0.01%
+32,080
New +$16.4K
ARMP icon
8770
Armata Pharmaceuticals
ARMP
$167M
$9K ﹤0.01%
3,095
+584
+23% +$2.85K
CLDX icon
8771
Celldex Therapeutics
CLDX
$3.24B
$9K ﹤0.01%
3,105
-5,530
-64% -$27.2K
GURE
8772
Gulf Resources
GURE
$4.71M
$9K ﹤0.01%
+241
New +$10.6K
MLSS icon
8773
Milestone Scientific
MLSS
$43.8M
$9K ﹤0.01%
27,322
+10,736
+65% +$5.75K
MVIS icon
8774
CALL
Microvision
MVIS
$52.6M
$9K ﹤0.01%
973
-3,747
-79% -$52.7K
PLUR icon
8775
PUT
Pluri
PLUR
$18.5M
$9K ﹤0.01%
+149
New +$12.8K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.